This invention relates to novel compounds which are ACAT inhibitors rendering them useful in lowering blood cholesterol levels. The compounds are carbamates represented by the general formula
wherein Ar and Ar represent phenyl, naphthyl or heteroaryl, each of which may be substituted; Z and W are hydrogen, aliphatic hydrocarbon, heterocyclic, aryl or carbocyclic containing groups. This invention also relates to a process for preparing the new compounds and to pharmaceutical compositions containing them.
本发明涉及新型化合物,它们是 ACAT
抑制剂,可用于降低血液中的
胆固醇水平。这些化合物是由通式表示的
氨基甲
酸酯类化合物
其中 Ar 和 Ar 代表苯基、
萘基或杂芳基,每个苯基、
萘基或杂芳基都可以被取代;Z 和 W 代表氢、脂肪烃、杂环、芳基或含碳环的基团。本发明还涉及制备新化合物的工艺和含有新化合物的药物组合物。